IL1B and COVID-19: Colchicine works by interfering with COVID-19 related manifestations such as hyper-inflammation, and inhibits inflammasome activation, neutrophil chemotaxis and the production of pro-inflammatory cytokines such as interleukin-1beta (IL-1β) and interleukin-18 (IL-18) (98, 100, 101).